Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia
Authors
Keywords
-
Journal
Neuroscience Bulletin
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-06
DOI
10.1007/s12264-021-00740-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polygenic Risk Scores Shed Light on the Relationship between Schizophrenia and Cognitive Functioning: Review and Meta-Analysis
- (2020) Jasmina Mallet et al. Journal of Clinical Medicine
- Emerging 5-HT receptor antagonists for the treatment of Schizophrenia
- (2020) Mackenzie T. Jones et al. EXPERT OPINION ON EMERGING DRUGS
- Social Cognition Training for People With a Psychotic Disorder: A Network Meta-analysis
- (2020) Saskia A Nijman et al. SCHIZOPHRENIA BULLETIN
- Network modules linking expression and methylation in prefrontal cortex of schizophrenia
- (2020) Dongdong Lin et al. Epigenetics
- Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist
- (2020) Cristina Cosi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pathophysiology of negative symptom dimensions of schizophrenia – Current developments and implications for treatment
- (2020) Indrit Bègue et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Corrigendum: DNA Methylation and Gene Expression of Matrix Metalloproteinase 9 Gene in Deficit and Non-deficit Schizophrenia
- (2020) Ju Gao et al. Frontiers in Genetics
- Polygenic scores for schizophrenia and general cognitive ability: associations with six cognitive domains, premorbid intelligence, and cognitive composite score in individuals with a psychotic disorder and in healthy controls
- (2020) Magnus Johan Engen et al. Translational Psychiatry
- Glutamate Hypothesis in Schizophrenia
- (2019) Yota Uno et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function
- (2019) Helene A Fachim et al. Epigenomics
- Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine
- (2019) Elias Wagner et al. SCHIZOPHRENIA RESEARCH
- Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia
- (2019) Istvan Bitter et al. NEUROPSYCHOPHARMACOLOGY
- Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
- (2019) Chun-Hung Chang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neuroinflammation and cognition across psychiatric conditions
- (2019) Célia Fourrier et al. CNS SPECTRUMS
- The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors
- (2019) Wolfgang Fleischhacker et al. EUROPEAN PSYCHIATRY
- Deep Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia
- (2019) Sergio Linsambarth et al. JOURNAL OF ECT
- Effects of a GWAS-Supported Schizophrenia Variant in the DRD2 Locus on Disease Risk, Anhedonia, and Prefrontal Cortical Thickness
- (2019) Margarita V. Alfimova et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Reduced DNA Methylation of the Oxytocin Receptor Gene Is Associated With Anhedonia-Asociality in Women With Recent-Onset Schizophrenia and Ultra-high Risk for Psychosis
- (2019) Minji Bang et al. SCHIZOPHRENIA BULLETIN
- Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial
- (2019) Jonathan Rabinowitz et al. SCHIZOPHRENIA RESEARCH
- Evaluation of Differences in Individual Treatment Response in Schizophrenia Spectrum Disorders
- (2019) Stephanie Winkelbeiner et al. JAMA Psychiatry
- Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
- (2019) Amanda Krogmann et al. CNS SPECTRUMS
- Transcranial direct current stimulation: a roadmap for research, from mechanism of action to clinical implementation
- (2019) Henry W. Chase et al. MOLECULAR PSYCHIATRY
- Effects of Roluperidone (MIN-101) on two dimensions of the negative symptoms factor score: Reduced emotional experience and reduced emotional expression
- (2019) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- Investigational and Therapeutic Applications of Transcranial Magnetic Stimulation in Schizophrenia
- (2019) Urvakhsh Meherwan Mehta et al. Current Psychiatry Reports
- Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia
- (2019) Liansheng Zhao et al. Neuroscience Bulletin
- Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate
- (2019) A.J. Robison et al. BIOLOGICAL PSYCHIATRY
- Meditation-based mind-body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis
- (2019) Michel Sabe et al. SCHIZOPHRENIA RESEARCH
- Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia
- (2019) Leandro da Costa Lane Valiengo et al. JAMA Psychiatry
- Spatial genome exploration in the context of cognitive and neurological disease
- (2019) Prashanth Rajarajan et al. CURRENT OPINION IN NEUROBIOLOGY
- Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia
- (2019) ChangWei Wei et al. PSYCHONEUROENDOCRINOLOGY
- Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia
- (2018) B. Galling et al. ACTA PSYCHIATRICA SCANDINAVICA
- Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms
- (2018) Richard S. E. Keefe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: Meta-analysis of controlled trials
- (2018) André Aleman et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients – A randomized controlled trial
- (2018) Ning Ding et al. NEUROSCIENCE LETTERS
- Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels
- (2018) Lulu Zhang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Social Skills Training for Negative Symptoms of Schizophrenia
- (2018) Eric Granholm et al. SCHIZOPHRENIA BULLETIN
- The effects of add-on fronto-temporal transcranial direct current stimulation (tDCS) on auditory verbal hallucinations, other psychopathological symptoms and insight in schizophrenia: A randomized, double-blind, sham-controlled trial
- (2018) Chuan-Chia Chang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Memory and cognition in schizophrenia
- (2018) J. Y. Guo et al. MOLECULAR PSYCHIATRY
- Adjunct transcranial direct current stimulation improves cognitive function in patients with schizophrenia: A double-blind 12-week study
- (2018) Dong-Wook Jeon et al. SCHIZOPHRENIA RESEARCH
- Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia
- (2018) J.P. Lindenmayer et al. Brain Stimulation
- Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies
- (2018) Stephen Marder et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap
- (2018) Sohei Kimoto et al. NEUROBIOLOGY OF DISEASE
- Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial
- (2018) Feikang Xu et al. PSYCHOPHARMACOLOGY
- Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
- (2018) Michael J. Gandal et al. SCIENCE
- Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk
- (2018) Prashanth Rajarajan et al. SCIENCE
- Effect of Damaging Rare Mutations in Synapse-Related Gene Sets on Response to Short-term Antipsychotic Medication in Chinese Patients With Schizophrenia
- (2018) Qiang Wang et al. JAMA Psychiatry
- The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions
- (2018) Aakash V. Sathappan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Transcranial Direct Current Stimulation over the Dorsolateral Prefrontal Cortex in Schizophrenia: A Quantitative Review of Cognitive Outcomes
- (2017) Joshua E. Mervis et al. Frontiers in Human Neuroscience
- Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia
- (2017) Willie Earley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
- (2017) Henry Barron et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and Acceptability of Cariprazine in Acute Exacerbation of Schizophrenia
- (2017) Ming-jun Zhao et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Bipolar disorder risk gene FOXO6 modulates negative symptoms in schizophrenia: a neuroimaging genetics study
- (2017) Joseph J. Shenker et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Schizophrenia, primary negative symptoms, and soft outcomes in psychiatry
- (2017) Stefan Leucht et al. LANCET
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability
- (2017) Tarjinder Singh et al. NATURE GENETICS
- Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence
- (2017) Suzanne Sniekers et al. NATURE GENETICS
- Genetic insights into the neurodevelopmental origins of schizophrenia
- (2017) Rebecca Birnbaum et al. NATURE REVIEWS NEUROSCIENCE
- Spatial organization of genome architecture in neuronal development and disease
- (2017) Yuki Fujita et al. NEUROCHEMISTRY INTERNATIONAL
- Home Use, Remotely Supervised, and Remotely Controlled Transcranial Direct Current Stimulation: A Systematic Review of the Available Evidence
- (2017) Ulrich Palm et al. NEUROMODULATION
- The influence of the glutamatergic system on cognition in schizophrenia: A systematic review
- (2017) Elizabeth H.X. Thomas et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis
- (2017) Nikolaos Koutsouleris et al. SCHIZOPHRENIA BULLETIN
- A Meta-Analysis of Social Skills Training and Related Interventions for Psychosis
- (2017) David T Turner et al. SCHIZOPHRENIA BULLETIN
- Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases
- (2017) Armida Mucci et al. SCHIZOPHRENIA RESEARCH
- Secondary negative symptoms — A review of mechanisms, assessment and treatment
- (2017) Matthias Kirschner et al. SCHIZOPHRENIA RESEARCH
- The current conceptualization of negative symptoms in schizophrenia
- (2017) Stephen R. Marder et al. World Psychiatry
- Identification of Genetic Loci Jointly Influencing Schizophrenia Risk and the Cognitive Traits of Verbal-Numerical Reasoning, Reaction Time, and General Cognitive Function
- (2017) Olav B. Smeland et al. JAMA Psychiatry
- How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression
- (2017) Aron Tendler et al. Jove-Journal of Visualized Experiments
- Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits
- (2017) Vinita Jagannath et al. Frontiers in Psychiatry
- Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis
- (2016) Bartosz Helfer et al. AMERICAN JOURNAL OF PSYCHIATRY
- The dopamine D3 receptor, a quarter century later
- (2016) Pierre Sokoloff et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cariprazine in the treatment of schizophrenia
- (2016) Suresh Durgam et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
- (2016) Ragy R Girgis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Schizophrenia
- (2016) Michael J Owen et al. LANCET
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects
- (2016) Christian R Marshall et al. NATURE GENETICS
- Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders
- (2016) Tarjinder Singh et al. NATURE NEUROSCIENCE
- Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia
- (2016) Giulio Genovese et al. NATURE NEUROSCIENCE
- Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
- (2016) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Spatial genome organization and cognition
- (2016) Prashanth Rajarajan et al. NATURE REVIEWS NEUROSCIENCE
- Cognition and resting-state functional connectivity in schizophrenia
- (2016) Julia M. Sheffield et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: A randomized rater blind-sham controlled study
- (2016) Shobit Garg et al. PSYCHIATRY RESEARCH
- Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction
- (2016) Anderson A Butler et al. Epigenomics
- The Future is The Past: Methylation QTLs in Schizophrenia
- (2016) Anke Hoffmann et al. Genes
- Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study
- (2015) Georgios Petrides et al. AMERICAN JOURNAL OF PSYCHIATRY
- Left Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation for the Treatment of Schizophrenia with Predominant Negative Symptoms: A Sham-Controlled, Randomized Multicenter Trial
- (2015) Thomas Wobrock et al. BIOLOGICAL PSYCHIATRY
- The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
- (2015) Darrick T Balu et al. CURRENT OPINION IN PHARMACOLOGY
- Transcranial magnetic stimulation, transcranial direct current stimulation and electroconvulsive therapy for medication-resistant psychosis of schizophrenia
- (2015) Wendy Nieuwdorp et al. CURRENT OPINION IN PSYCHIATRY
- Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949)
- (2015) G Davies et al. MOLECULAR PSYCHIATRY
- Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex
- (2015) Andrew E Jaffe et al. NATURE NEUROSCIENCE
- Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci
- (2015) Eilis Hannon et al. NATURE NEUROSCIENCE
- Altered epigenetic regulation in early development associated with schizophrenia
- (2015) Hemi Malkki Nature Reviews Neurology
- Social cognition in schizophrenia
- (2015) Michael F. Green et al. NATURE REVIEWS NEUROSCIENCE
- The muscarinic system, cognition and schizophrenia
- (2015) Sean P. Carruthers et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Transcranial Magnetic Stimulation for Schizophrenia
- (2015) Nadine Dougall et al. SCHIZOPHRENIA BULLETIN
- Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial
- (2015) Alkomiet Hasan et al. SCHIZOPHRENIA BULLETIN
- Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes: Table 1.
- (2015) Alexis C. Edwards et al. SCHIZOPHRENIA BULLETIN
- Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort
- (2015) Stephen F. Austin et al. SCHIZOPHRENIA RESEARCH
- How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis
- (2015) Tyrone D. Cannon TRENDS IN COGNITIVE SCIENCES
- Recovery, not progressive deterioration, should be the expectation in schizophrenia
- (2015) Robert B. Zipursky et al. World Psychiatry
- Ventral Striatal Activation During Reward Processing in Psychosis
- (2015) Joaquim Radua et al. JAMA Psychiatry
- An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
- (2015) Akihiro Shiina et al. Clinical Psychopharmacology and Neuroscience
- Psychological Interventions for Psychosis: A Meta-Analysis of Comparative Outcome Studies
- (2014) David Trevor Turner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study
- (2014) Antoni Sicras-Mainar et al. BMC Psychiatry
- Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia
- (2014) Wolfgang Wölwer et al. Brain Stimulation
- Double-blind, randomized sham controlled study of deep-TMS add-on treatment for negative symptoms and cognitive deficits in schizophrenia
- (2014) Liron Rabany et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neurobiology and treatment of first-episode schizophrenia
- (2014) R S Kahn et al. MOLECULAR PSYCHIATRY
- Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study
- (2014) Mohammad-Reza Khodaie-Ardakani et al. PSYCHIATRY RESEARCH
- Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial
- (2014) J. J. Dlabac-de Lange et al. PSYCHOLOGICAL MEDICINE
- Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data
- (2014) M. Savill et al. PSYCHOLOGICAL MEDICINE
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial
- (2014) Suresh Durgam et al. SCHIZOPHRENIA RESEARCH
- Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
- (2014) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Variability in Working Memory Performance Explained by Epistasis vs Polygenic Scores in theZNF804APathway
- (2014) Kristin K. Nicodemus et al. JAMA Psychiatry
- Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2
- (2013) Ludmila F.M.F. Cardozo et al. BIOCHIMIE
- CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1
- (2013) E. Rees et al. HUMAN MOLECULAR GENETICS
- Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: An updated meta-analysis of randomized placebo-controlled trials
- (2013) Yuki Matsuda et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Systematic meta-analysis of childhood social withdrawal in schizophrenia, and comparison with data from at-risk children aged 9–14 years
- (2013) Sandra L. Matheson et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia
- (2013) Melissa J. Green et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- CNVs conferring risk of autism or schizophrenia affect cognition in controls
- (2013) Hreinn Stefansson et al. NATURE
- Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases
- (2013) Robert A Lasser et al. NEUROPSYCHOPHARMACOLOGY
- BCL9 and C9orf5 Are Associated with Negative Symptoms in Schizophrenia: Meta-Analysis of Two Genome-Wide Association Studies
- (2013) Chun Xu et al. PLoS One
- Methylation Patterns in Whole Blood Correlate With Symptoms in Schizophrenia Patients
- (2013) Jingyu Liu et al. SCHIZOPHRENIA BULLETIN
- Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia
- (2013) Borja García-Bueno et al. SCHIZOPHRENIA BULLETIN
- The diminished interhemispheric connectivity correlates with negative symptoms and cognitive impairment in first-episode schizophrenia
- (2013) Tumbwene E. Mwansisya et al. SCHIZOPHRENIA RESEARCH
- Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: A pooled analysis
- (2013) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- Pharmacological approaches to treating negative symptoms: A review of clinical trials
- (2013) Celso Arango et al. SCHIZOPHRENIA RESEARCH
- Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: A CATIE analysis
- (2013) Jonathan Rabinowitz et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia Is a Cognitive Illness
- (2013) René S. Kahn et al. JAMA Psychiatry
- CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics
- (2012) Dheeraj Malhotra et al. CELL
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Dynamics of DNA Methylation in Schizophrenia and Related Psychiatric Disorders
- (2012) Dennis R Grayson et al. NEUROPSYCHOPHARMACOLOGY
- Negative symptoms in individuals at clinical high risk of psychosis
- (2012) Danijela Piskulic et al. PSYCHIATRY RESEARCH
- Flat affect and social functioning: A 10year follow-up study of first episode psychosis patients
- (2012) Julie Evensen et al. SCHIZOPHRENIA RESEARCH
- Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications
- (2011) Young-Sam Keum Annals of the New York Academy of Sciences
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- (2011) Surendra P. Singh et al. CNS DRUGS
- Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study
- (2011) Yechiel Levkovitz et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
- (2011) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
- (2011) Richard S. E. Keefe et al. SCHIZOPHRENIA BULLETIN
- Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms
- (2011) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- Cognition in schizophrenia: core psychological and neural mechanisms
- (2011) Deanna M. Barch et al. TRENDS IN COGNITIVE SCIENCES
- Targeting glutamate synapses in schizophrenia
- (2011) Julie R. Field et al. TRENDS IN MOLECULAR MEDICINE
- Psychosis Susceptibility Gene ZNF804A and Cognitive Performance in Schizophrenia
- (2010) James T. R. Walters et al. ARCHIVES OF GENERAL PSYCHIATRY
- Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis
- (2010) Surendra P. Singh et al. BRITISH JOURNAL OF PSYCHIATRY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia
- (2010) Yan Wang et al. PSYCHIATRY RESEARCH
- Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice
- (2009) Julio Bobes et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond
- (2009) E. Bora et al. SCHIZOPHRENIA BULLETIN
- Negative symptoms in schizophrenia—A review
- (2008) J Mäkinen et al. NORDIC JOURNAL OF PSYCHIATRY
- Development of social functioning in preschizophrenia children and adolescents: A systematic review.
- (2008) Sarah I. Tarbox et al. PSYCHOLOGICAL BULLETIN
- Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
- (2008) J. van Os et al. SCHIZOPHRENIA BULLETIN
- Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation
- (2008) M KURTZ et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search